Discover published sets by community

IBD is most commonly diagnosed between the ages of 15 and 35, but it can occur at any age.

IBD has a genetic component, with a higher likelihood of the disease in individuals with a family history of IBD.

Patients with IBD, particularly those with ulcerative colitis, have an increased risk of developing colon cancer.

While IBD is associated with an increased risk of morbidity, it does not significantly reduce life expectancy when properly managed.

Approximately 1.6 million people in the United States have IBD, with 70,000 new cases diagnosed each year.

Several environmental factors have been associated with IBD, including smoking, diet, and use of nonsteroidal anti-inflammatory drugs (NSAIDs).

Up to 75% of people with Crohn's disease and 25-33% of those with ulcerative colitis will require surgery at some point.

The two main types of inflammatory bowel disease are Crohn's disease and ulcerative colitis.

IBD has a significant economic impact, with overall annual healthcare costs estimated to be between $14.6 and$31.6 billion in the US.